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T-BET, FOXP3 AND CD8 REGULATING IMMUNE RESPONSE 
IN COLORECTAL CANCER 
 
Colorectal cancer (CRC) is the third most common cancer diagnosed, 
and is associated with high rates of propagation and mortality for both men 
and women. Aimed to to analyze impact of presence of T-bet, Foxp3 and 
CD8 on colorectal cancer. During the period 1/October/2013 to 
1/March/2014, fifty patients with colon cancer (14 female and 36 male) (7-
75) years were taken from (Al-Hussain Hospital City/Kerbala, Digestive 
and Liver Disease /Education Hospital Medical City Baghdad and Teaching 
Oncology Hospital /Baghdad Medical City/ Baghdad 
/Iraq).Immunochemical studying of T-bet, Foxp3 and CD8 of colorectal 
biopsies by using DAKO Company/Denmark. There was a significant 
increase (p≤0.001) in the concentration of T-bet, Foxp3 and CD8 
respectively in patients male compared with female, also there was a 
significant variance (p≤0.001) in the three age groups from (7-20), (21-40) 
and (41-75) in the levels of T-bet and CD8, whereas a significant difference 
(p≤0.05) in the concentration of Foxp3 in the three age groups. This study 
proved functional role of T-bet, Foxp3 and CD8 in cell-mediated immunity. 
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Introduction  
Colorectal cancer (CRC) is the third most 
common cancer diagnosed, and is associated with 
high rates of propagation and mortality for both 
men and women [1]. 
Subsets of immune cells can inhibit 
immunological interaction with tumor cells. The 
clinical impact of T cells that are supposed to be 
responsible for the down regulation of a T cell 
response: regulatory T cells [2]. 
The mechanisms that inhance a protective T-cell 
response in the tumor microenvironment remain 
unclear [3]. 
Forkhead Box P3 FOXP3, which encodes for 
helix transcription factor called Scurfin, has been 
identified to be a key regulatory gene required for 
the development and functional activity of 
regulatory T cells. CD4 and CD8, T-cell can 
suppressed by Tregs that responses to auto- and 
alloantigens in a contact dependent fashion [4-5]. 
Studies suggest that T-bet is essential for the 
development of terminally differentiated CD27, 
CD11 NK cells [6-7]. 
A novel transcription factor T-box expressed in 
T cells (T-bet) behaves as the regulator of Th1 
development. Macrophage and antigenic 
stimulation induce T-bet derived IL-12/IL-18 are 
important for establishing Th1 mediated 
immunopathology in CD [8]. 
Role of CD8+ T cells expressing cytotoxic 
molecules really spend in a specific immune 
response against the tumor cells in vivo unclear [9]. 
Tumor infiltration of CD4+ and CD8+ (T-bet+) 
effector T cells contribute in the enhancement of T 
cell activation through T cell receptor stimulation 
and co-stimulatory signals provides promising 
strategies for immunotherapy of colon cancer [10]. 
Aim of study to evaluate the role of T-bet, 
Foxp3 and CD8 in Patients with Colorectal Cancer. 
Patients and Methods 
Selection of patients 
During the period 1/October/2013 to 
1/March/2014, fifty patients with colon cancer (14 
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female and 36 male) (7-75) years were taken from 
(Al-Hussain Hospital City/Kerbala, Digestive and 
Liver Disease /Education Hospital Medical City 
Baghdad and Teaching Oncology Hospital 
/Baghdad Medical City/ Baghdad /Iraq). 
Sample collection and assay procedure 
Tumors were staged according to the TNM 
criteria [11]. Known tumor characteristics included 
differentiation grade. 
 
(Table 1) 
The clinical characteristic of patients with 
colorectal cancer 
Characteristic N % 
No of patients 50 100 
Sex 
Male 
Female 
 
36 
14 
 
72 
28 
Age(years) 
Median 
Range 
 
59 
7-75 
 
 
TNM 
Duke A 
Duke B 
Duke C 
 
5 
28 
17 
 
10 
56 
34 
Characteristic N % 
No of patients 50 100 
Sex 
Male 
Female 
 
36 
14 
 
72 
28 
Age(years) 
Median 
Range 
 
59 
7-75 
 
 
TNM 
Duke A 
Duke B 
Duke C 
 
5 
28 
17 
 
10 
56 
34 
 
Novolink polymer detection systems: 
FFPE (formalin-fixed paraffin-embedded) tissue 
sections of 5 μm thickness were prepared on 
aminopropylethoxysilane (APES)-coated slides and 
dried at 37°C. De-paraffinzed sections in two 
changes of xylene of 4 min. each. Xylene 1---
xylene 2, re-hydrated sections through graded 
ethanol of 4 min. each wash in tap water. Antigen 
unmasked in tris-EDTA buffer pH9 (800 watt) or 
sodium citrate pH 6(600 watt) and microwaved for 
25 min. After cooling for 15 min. for 30 min. 
Biopsies were washed in deionized water. One –
two drops Peroxidase Block were added for 5 min. 
then washed in PBS for 2x5 min. at room 
temperature, then washed with PBS1-PBS2. One –
two drops Protein Block were added for 5 min. then 
washed in PBS for 2x5 min. wash PBS1-PBS2. 50 
µl was added for each section prepare monoclonal 
Abs 1 µ l/100 ml PBS (anti-IL-17, anti-perforin and 
anti-CD68), then incubated for 1 hrs.in room temp, 
then washed with PBS1-PBS. One drop Post 
primary Block solution was added for 30 min, then 
washed with PBS1-PBS2. One drop of Polymer AB 
secondary Ab was added for 30 min. wash PBS1-
PBS2. DAB Buffer 50 µl was added for each 
section.  One µl DAB /50 µl DAB Buffer. Then 
incubated for 8 min. wash PBS1-PBS2. One drop of 
Hematoxyline was added for 1 min to 1.5 min, then 
washed with PBS1-PBS2 and with tap water, one 
drop of oil-cover was added. 
Microscopic analysis 
Were calculated with ‘0’ equaling no positive 
cells,’1’minimal (5%),’2’ moderate (5-10%),’3-4’ 
abundant (>10%) quantities of positive cells [12]. 
Statistical analysis 
Results are expressed as mean ± standard 
deviation (SD), student t-test, ANOVA and Pearson 
correlation were used to analyze results by using 
SPSS version 22. P-value ≤ 0.05 was considered 
significant.  
Results 
Fifty colorectal cancer biopsies specimens 
patients were evaluated, thirty six of 50 patients 
were male (72%) and fourteen (28%) were female. 
Median age at diagnosed was (59) range 7-75 years. 
All patients had stages A, B and C according to 
Duke score (Table 1).  
There was a significant increase (p≤0.001) in 
the concentration of T-bet, Foxp3 and CD8 
respectively in patients male compared with female, 
also there was a significant variance (p≤0.001) in 
the three age groups from (7-20), (21-40) and (41-
75) in the levels of T-bet and CD8, whereas a 
significant difference (p≤0.05) in the concentration 
of Foxp3 in the three age groups. According to the 
Duke score, the results revealed a significant 
difference (p≤0.001) in the levels of the T-bet, 
Foxp3 and CD8 in the three stage groups of patients 
(Table 2, Figure 1). 
In (Table 3) there was a highly positive 
correlation among T-bet with CD8 and Foxp3 
(r=0.7, p≤0.001) and (r= 0.6, p≤0.001) respectively. 
Also, there was a positive correlation (r=0.6, 
p≤0.001). 
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(Table 2)  
The levels of T-bet, Foxp3 and CD8 in patients of colorectal cancer. 
Characteristic (No) T-bet 
Mean SD 
p-value Foxp3 
Mean SD 
p-value CD8 
Mean SD 
p-value 
Gender 
Male(36) 
Female(14) 
2.03 0.9 
0.5 0.4 
 
0.0001 
3.05 0.6 
1.5 0.5 
 
0.0001 
2.8 0.6 
1.9 0.6 
 
0.0001 
Age 
(7-20) 3 
(21-40)5 
(41-75)42 
0.33 0.05 
0.6 0.5 
1.8 1 
 
 
0.0001 
1.6 0.5 
2 1 
2.7 0.8 
 
 
0.035 
1.7 0.5 
2.2 0.8 
2.7 0.7 
 
 
0.0001 
 
TNM 
Duke A (5) 
Duke B (28) 
Duke C (17) 
 
0.2 0.04 
1.4 1 
2.03 0.8 
 
 
0.0001 
 
1.4 0.5 
2.05 0.8 
3.2 0.4 
 
 
0.0001 
 
1.6 0.5 
2.1 0.6 
3.03 0.5 
 
 
0.0001 
 
(Table 3)  
The correlation of the parameters under study in patients of colorectal cancer 
parameters r p-value 
Tbet vs. Foxp3 0.7 0.0001 
Tbet vs. CD8 0.6 0.0001 
Foxp3 vs. CD8 0.6 0.0001 
 
Figure 1. 
Immunohistochemical staining of colorectal biopsies. 
 
 
 
 
 
 
 
 
 
 
1. Duck/B/T3N0MxStage/2A,  
2. Malignant Stage/C/T3N1Mx,  
3. Malignant Duck/C1/T3N1Mx/Stage/3A. (Original magnification x400) 
 
Discussion  
The current study provided evidence strongly 
role of Foxp3 expression, T-bet and CD8 in 
colorectal cancer.  
T-bet regulates the relationship between 
mucosal innate immune cells and the intestinal 
microbiota that played by T-bet in controlling the 
profile of cytokines produced by T-cells [13]. 
T-bet has been suggested to be master regulators 
of Th1 cells and CD8+ T cells antitumor, their 
importance for T cell-mediated antitumor immunity 
is controversial [14]. 
 The presence of FOXP3+Treg cells in 
colorectal cancer and the relationship of FOXP3 
expression with clinicopathological features of 
colorectal cancer [15]. 
Presence of Foxp3 cells in tumor tissues shows 
the interplay between members of the immune 
system in CRC patients that hypothesized local 
interactions in the cancer microenvironment 
between tumor cells and immune cells [2]. 
FOXP3 appears to have a specific role in the 
progression of the primary tumour due to its 
association noted with tumour size, Suggested as 
biomarkers for prognosis and future 
immunotherapeutic strategies [16]. 
FOXP3+Treg cells detection may be useful in 
prognosis of patients with colorectal cancer [15]. 
1 2 3 
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Researchers suggested CD3, CD4 and CD8 may 
play a role in the immunopathogenesis of colorectal 
cancer [17]. 
 
Conclusion 
Potential functional role of T-bet,Foxp3 and 
CD8 in colorectal cancer was explained interaction 
between tumor cells and immune cells that appear 
immunopathagenesis explanation .This study 
recommend more immunogenetic studies dehisce 
new prospects to testing a better  therapeutics  for 
colorectal cancer. 
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